HomeAbout

TL;DR CNBC


Anat Ashkenazi - TL;DR CNBC

Anat Ashkenazi

Publishing timestamp: 2024-02-28 05:50:01


Summary

Anat Ashkenazi, the Executive Vice President & Chief Financial Officer of Eli Lilly and Company, played a key role in managing a big revenue boost, investment in new manufacturing, creating jobs, and lowering insulin prices in 2023. The company's success in sales of weight loss and diabetes drugs, along with the launch of new treatments, helped Eli Lilly become the most valuable publicly traded drug company in the world. Ashkenazi also helped the company navigate challenges such as high demand for their drugs and criticism of high prices by doubling production capacity and reducing insulin prices.


Sentiment: POSITIVE

Tickers: LLY

Keywords: eli lilly and comediabusiness newsexclude from automated curation

Source: https://www.cnbc.com/2024/02/28/anat-ashkenazi-cnbc-changemakers.html


Developed by Leo Phan